Edwards Lifesciences
1,220 hedge funds and large institutions have $58B invested in Edwards Lifesciences in 2021 Q3 according to their latest regulatory filings, with 124 funds opening new positions, 437 increasing their positions, 410 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,220
Holders Change
+42
Holders Change %
+3.57%
% of All Funds
21.43%
Holding in Top 10
21
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+23.53%
% of All Funds
0.37%
New
124
Increased
437
Reduced
410
Closed
68
Calls
$249M
Puts
$214M
Net Calls
+$34.7M
Net Calls Change
-$85M
Top Buyers
| 1 |
Two Sigma Advisers
New York
|
+$146M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$134M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$122M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$113M |
| 5 |
Korea Investment Corp
Seoul,
South Korea
|
+$93.8M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$199M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$188M |
| 3 |
DCP
D1 Capital Partners
New York
|
-$126M |
| 4 |
KBC Group
Brussels,
Belgium
|
-$120M |
| 5 |
Bank of New York Mellon
New York
|
-$117M |
